[
  {
    "compound_1": "CBD",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 22.1
  },
  {
    "compound_1": "THC",
    "compound_2": "nabiximols",
    "effect_size": null,
    "source": "invalid",
    "pmid": null,
    "evidence_type": "invalid",
    "confidence": null,
    "notes": "22 PubMed results. No RCT augmenting nabiximols with additional THC found. Nabiximols already contains THC (Sativex = THC:CBD 1:1) \u00e2\u20ac\u201d pairing with isolated THC is structurally redundant. Flagged invalid Feb 27, 2026.",
    "priority_score": 18.95
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "nabiximols",
    "effect_size": 0.3,
    "source": "literature",
    "pmid": "21289620",
    "evidence_type": "rct",
    "confidence": "low",
    "notes": "Karschner et al., Clin Pharmacol Ther 2011 (randomized crossover N=9). Oral dronabinol vs. nabiximols head-to-head. Finding: pharmacodynamically equivalent at therapeutic doses \u00e2\u20ac\u201d no substantial CBD-induced modulation of THC's effects. Comparative equivalence design, NOT additive co-administration. Effect size set conservatively low (0.30). Feb 27, 2026.",
    "priority_score": 18.6
  },
  {
    "compound_1": "CBD",
    "compound_2": "CBDV",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 18.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "CBC",
    "effect_size": 0.35,
    "source": "literature",
    "pmid": "37162192",
    "evidence_type": "rct",
    "confidence": "moderate",
    "notes": "Saleska et al., J Am Nutr Assoc 2024;43(1):1-11. RCT N=1,793. 15mg CBD + 5mg CBC vs CBD isolate for sleep disturbance (PROMIS SF-8A). No significant difference between CBC-augmented and CBD-alone arms. Null augmentation finding \u00e2\u20ac\u201d CBC adds no measurable benefit to CBD for sleep at this dose. Effect size set conservatively (0.35) to reflect real-signal null evidence. Feb 27, 2026.",
    "priority_score": 18.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 18.4
  },
  {
    "compound_1": "nabilone",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 18.2
  },
  {
    "compound_1": "CBD",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 17.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 17.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 17.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 16.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 16.4
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.7
  },
  {
    "compound_1": "CBD",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.4
  },
  {
    "compound_1": "CBD",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.4
  },
  {
    "compound_1": "THC",
    "compound_2": "CBDV",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.25
  },
  {
    "compound_1": "THC",
    "compound_2": "CBC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.25
  },
  {
    "compound_1": "THC",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 15.25
  },
  {
    "compound_1": "CBDV",
    "compound_2": "dronabinol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.9
  },
  {
    "compound_1": "CBC",
    "compound_2": "dronabinol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.9
  },
  {
    "compound_1": "CBG",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.7
  },
  {
    "compound_1": "CBN",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.7
  },
  {
    "compound_1": "THCV",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.7
  },
  {
    "compound_1": "CBDV",
    "compound_2": "nabilone",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.5
  },
  {
    "compound_1": "CBC",
    "compound_2": "nabilone",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.5
  },
  {
    "compound_1": "THC",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.25
  },
  {
    "compound_1": "THC",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.25
  },
  {
    "compound_1": "THC",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 14.25
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.9
  },
  {
    "compound_1": "CBDV",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.7
  },
  {
    "compound_1": "CBC",
    "compound_2": "nabiximols",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.7
  },
  {
    "compound_1": "nabilone",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.5
  },
  {
    "compound_1": "THC",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.25
  },
  {
    "compound_1": "THC",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 13.25
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.9
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.7
  },
  {
    "compound_1": "nabilone",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.5
  },
  {
    "compound_1": "THC",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.25
  },
  {
    "compound_1": "THC",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.25
  },
  {
    "compound_1": "THC",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.25
  },
  {
    "compound_1": "THC",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.25
  },
  {
    "compound_1": "THC",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.25
  },
  {
    "compound_1": "CBDV",
    "compound_2": "Delta8-THC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "Delta8-THC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 12.0
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.9
  },
  {
    "compound_1": "dronabinol",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.9
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.7
  },
  {
    "compound_1": "nabilone",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.5
  },
  {
    "compound_1": "nabilone",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.5
  },
  {
    "compound_1": "CBG",
    "compound_2": "CBDV",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "CBC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "CBDV",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "CBC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "CBDV",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "CBC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 11.0
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.7
  },
  {
    "compound_1": "nabiximols",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.7
  },
  {
    "compound_1": "CBG",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "CBC",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "beta-caryophyllene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 10.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "Delta8-THC",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "myrcene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 9.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBG",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBN",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "THCV",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "limonene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "linalool",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 8.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBDV",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "CBC",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "beta-caryophyllene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "alpha-pinene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 7.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "myrcene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "limonene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "linalool",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "alpha-pinene",
    "compound_2": "humulene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 6.0
  },
  {
    "compound_1": "alpha-pinene",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "alpha-pinene",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "alpha-pinene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "alpha-pinene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "alpha-pinene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "humulene",
    "compound_2": "terpinolene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "humulene",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "humulene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "humulene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "humulene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 5.0
  },
  {
    "compound_1": "terpinolene",
    "compound_2": "ocimene",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "terpinolene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "terpinolene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "terpinolene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "ocimene",
    "compound_2": "nerolidol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "ocimene",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "ocimene",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "nerolidol",
    "compound_2": "guaiol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "nerolidol",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  },
  {
    "compound_1": "guaiol",
    "compound_2": "alpha-bisabolol",
    "effect_size": 0.6211,
    "source": "model_prediction",
    "pmid": null,
    "evidence_type": "model_prediction",
    "confidence": "low",
    "notes": "Placeholder \u00e2\u20ac\u201d awaiting Phase 3 model prediction or literature sourcing.",
    "priority_score": 4.0
  }
]